# GPT Healthcare (NSE: GPTHEALTH) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/GPTHEALTH · Pivot · prices to 22 Oct 2026

GPT Healthcare (NSE: GPTHEALTH) closed at ₹135.22 on 22 Oct 2026, down 0.86% on the day. With a market capitalisation of ₹1,110 Cr, it ranks 1402nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

At its last close the stock traded at 26.3× trailing earnings, against a return on equity of 26.4% in FY22. Over the past year the share price has fallen 8.2%. Its 52-week range is ₹115.00 (27 Mar 2026) to ₹175.00 (31 Jul 2026); the last close is 22.7% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹126 Cr (+17.8% year on year) and net profit ₹13 Cr (+65.8%), on a standalone basis. Promoters held 65.57% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹135.22 |
| Market cap | ₹1,110 Cr |
| P/E (trailing) | 26.3 |
| ROE | 26.4% (FY22) |
| ROCE | 25.6% (FY22) |
| Debt to equity | 0.6 |
| 52-week high | ₹175.00 (31 Jul 2026) |
| 52-week low | ₹115.00 (27 Mar 2026) |
| 1-year return | −8.2% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹126 Cr | +17.8% | ₹13 Cr | +65.8% | ₹1.55 |
| Q4 FY26 | ₹126 Cr | +24.6% | ₹15 Cr | +13.0% | ₹1.78 |
| Q3 FY26 | ₹120 Cr | +17.6% | ₹9 Cr | −23.5% | ₹1.14 |
| Q2 FY26 | ₹119 Cr | +12.5% | ₹11 Cr | −28.5% | ₹1.29 |
| Q1 FY26 | ₹107 Cr | +9.5% | ₹8 Cr | −22.9% | ₹0.94 |
| Q4 FY25 | ₹101 Cr | +2.0% | ₹13 Cr | +0.5% | ₹1.57 |
| Q3 FY25 | ₹102 Cr | +5.8% | ₹12 Cr | +6.8% | ₹1.49 |
| Q2 FY25 | ₹106 Cr | −2.1% | ₹15 Cr | +9.7% | ₹1.81 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY22 | ₹337 Cr | ₹42 Cr |
| FY21 | ₹243 Cr | ₹21 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 65.57%
- Foreign institutions: 3.03%
- Domestic institutions: 6.94%
- Non-institutions: 24.46%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Anlon Healthcare](https://app.pivotnow.in/stock/AHCL) | ₹24.35 | ₹1,294 Cr | 39.9 | — |
| [Shalby](https://app.pivotnow.in/stock/SHALBY) | ₹118.16 | ₹1,276 Cr | 36.5 | — |
| [Bajaj Healthcare](https://app.pivotnow.in/stock/BAJAJHCARE) | ₹327.65 | ₹1,103 Cr | 48.6 | — |
| [Bafna Pharmaceuticals](https://app.pivotnow.in/stock/BAFNAPH) | ₹451.95 | ₹1,069 Cr | 96.4 | — |
| [Lincoln Pharmaceuticals](https://app.pivotnow.in/stock/LINCOLN) | ₹517.50 | ₹1,037 Cr | 11.8 | — |
| [Sigachi Industries](https://app.pivotnow.in/stock/SIGACHI) | ₹26.24 | ₹1,003 Cr | — | — |

## Questions and answers

### What is the share price of GPT Healthcare today?

GPT Healthcare (NSE: GPTHEALTH) last closed at ₹135.22 on 22 Oct 2026. Its 52-week high is ₹175.00 and its 52-week low is ₹115.00.

### What is the market cap of GPT Healthcare?

GPT Healthcare's market capitalisation is ₹1,110 Cr (₹1,110 Cr) at the 22 Oct 2026 close, ranking 1402nd among the NSE companies Pivot tracks.

### What is the P/E ratio of GPT Healthcare?

GPT Healthcare trades at a trailing P/E of 26.3. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 39.9.

### What is the ROE and ROCE of GPT Healthcare?

Return on equity was 26.4% in FY22 and return on capital employed was 25.6% in FY22 (consolidated figures).

### Is GPT Healthcare a debt-free company?

No. GPT Healthcare's debt-to-equity ratio was 0.6 in FY22, with total debt of ₹72 Cr.

### What were GPT Healthcare's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), GPT Healthcare reported revenue of ₹126 Cr, +17.8% year on year, and net profit of ₹13 Cr, +65.8% year on year.

### How has GPT Healthcare stock performed over the last year?

GPT Healthcare's share price has fallen 8.2% over the past year, −13.3% over three months and −17.6% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of GPT Healthcare?

As of 30 Jun 2026: promoters 65.57%, foreign institutions 3.03%, domestic institutions 6.94%, non-institutions 24.46%.

### Who are GPT Healthcare's competitors?

The listed Pharma & Healthcare companies closest to GPT Healthcare by market cap are Anlon Healthcare, Shalby, Bajaj Healthcare, Bafna Pharmaceuticals, Lincoln Pharmaceuticals and Sigachi Industries.

### Is GPT Healthcare a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out GPT Healthcare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on GPTHEALTH against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.